AzTrials
AzTrials

Abdominal InjuryNCT04058015

Outcome of Patients With Thoraco-abdominal Injury and Stress-induced Hyperglycemia or Diabetic Hyperglycemia

An observational study of Abdominal Injury and Thoracic Injury, run by Chang Gung Memorial Hospital at 1 site in Taiwan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aimed to measure the effects of SIH and DH on the mortality outcomes of the adult patients with moderate to severe thoracoabdominal injury Read more about this study

Who is it for?
Ages 20 to 100 years
Conditions the study is for
Abdominal Injury, Thoracic Injury, Hyperglycemia
What is being tested?
Stress-induced hyperglycemia, Diabetic hyperglycemia and Diabetic normoglycemia
How many people
802 participants
Where
1 siteTaiwan
Study dates
3 Jun 2019to 9 Aug 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 100 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: This retrospective study reviewed data from trauma patients registered between January 1, 2009 and December 31, 2018. The inclusion criteria were age ≥20 years Adult patients with moderate to severe thoracoabdominal injuries (n = 802) were grouped into four exclusive subgroups: (1) SIH, which was defined as a serum glucose ≥ 200 mg/dL in the patients without DM (n = 52); (2) DH, which indicated a serum glucose ≥ 200 mg/dL in patients with DM (n = 79); (3), DN, which was defined when there was a serum glucose < 200 mg/dL in the patients with DM (n = 50); and (4) NDN, indicating a serum glucose < 200 mg/dL in patients who were absent of DM (n = 621)

Who may be able to join

  • adult patients with moderate to severe thoracoabdominal injuries

Who cannot join

  • patients with a thoracic and abdominal abbreviated injury scale (AIS) < 3
  • patients who had polytrauma which was defined as there was additional AIS scores ≥ 3 points in other regions of the body
  • patients less than 20 years old
  • patients who had sustained a burn injury

Trial locations and contacts

1 site in 1 country.

Taiwan1 site
  • Kaohsiung Chang Gung Memorial Hospital

    Kaohsiung City, 83301

Other trials in Taiwan

About this study

Official title: Admission Hyperglycemia in Patients With Moderate to Severe Thoracoabdominal Injuries is Associated With Higher Mortality Rate Than Non-Diabetic Normoglycemic Patients

This study aimed to measure the effects of SIH and DH on the mortality outcomes of the adult patients with moderate to severe thoracoabdominal injury

Read the detailed description

Because the pathophysiologic response of the patients with a thoracoabdominal injury is different from those who had a traumatic brain injury, this study aimed to measure the effects of hyperglycemia induced by stress or by diabetes on the outcomes of patients with thoracoabdominal injuries in comparison with those who had non-diabetic normoglycemia (NDN). The primary study hypothesis stated that, following thoracoabdominal injuries, the patients with SIH had a worse outcome than patients with DH. The primary outcome was mortality rate of these patients.

Being tested
Stress-induced hyperglycemia, Diabetic hyperglycemia, Diabetic normoglycemia, Non-diabetic normoglycemia
Keywords
admission hyperglycemia, stress-induced hyperglycemia, diabetic hyperglycemia, diabetes mellitus, thoracoabdominal trauma, mortality
Medical subject headings
Abdominal Injuries, Thoracic Injuries, Hyperglycemia, Diabetes Mellitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Stress-induced hyperglycemiaOther

    Stress-induced hyperglycemia (SIH)was defined as a serum glucose ≥ 200 mg/dL in the patients without Diabetes mellitus.

  • Diabetic hyperglycemiaOther

    Diabetic hyperglycemia (DH) which indicated a serum glucose ≥ 200 mg/dL in patients with Diabetes mellitus.

  • Diabetic normoglycemiaOther

    Diabetic normoglycemia (DN), which was defined when there was a serum glucose < 200 mg/dL in the patients with Diabetes mellitus.

  • Non-diabetic normoglycemiaOther

    Non-diabetic normoglycemia (NDN) indicating a serum glucose < 200 mg/dL in patients who were absent of Diabetes mellitus.

Study groups in NCT04058015
Study groupRoleWhat they receive
adult patients with thoracoabdominal injuriesadult patients with moderate to severe thoracoabdominal injuries
Receives: Other: Stress-induced hyperglycemia; Other: Diabetic hyperglycemia; Other: Diabetic normoglycemia; Other: Non-diabetic normoglycemia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. in-hospital mortality

    The primary outcome of the study was in-hospital mortality.

    Measured: up to 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Aug 2019
  2. Study start3 Jun 2019
  3. Primary completion1 Jul 2019
  4. Study completion9 Aug 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Retrospective
Enrolment
802 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04058015
Sponsor's protocol ID
201900726B0
Status last verified
Jun 2019
First submitted
13 Aug 2019
Last updated
15 Aug 2019
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Abdominal Injury and Thoracic Injury, run by Chang Gung Memorial Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Aug 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

in-hospital mortality (time frame: up to 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Aug 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in